Delcath Systems, Inc.

DCTH ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $1.1M $790.0K $346.0K $0 $0
Cost of Revenue $291.0K $464.0K $39.0K $0 $0
Gross Profit $778.0K $326.0K $307.0K $0 $0
Gross Margin 72.8% 41.3% 88.7% — —
Operating Expenses
Research & Development $4.3M $12.7M $26.2M $25.2M $17.6M
SG&A Expense $15.8M $20.7M $28.0M $21.3M $13.2M
Operating Income $-19.3M $-33.0M $-53.9M $-46.5M $-30.7M
Operating Margin -1,805.8% -4,179.6% -15,569.7% — —
Interest Expense — — — — —
Pretax Income $-17.4M $-30.3M — — —
Income Tax Expense $0 $0 $0 — —
Net Income $-17.4M $-30.3M $-51.9M $-30.9M $-46.7M
Net Margin -1,625.9% -3,838.5% -14,990.8% — —
EPS (Basic) $-0.01 $-0.02 $-0.06 $0.00 $-0.01
EPS (Diluted) $-0.01 $-0.02 $-0.06 $0.00 $-0.01
Shares Outstanding (Basic) 2.12B 1.41B 857.9M 10.13B 9.62B
Shares Outstanding (Diluted) 2.12B 1.47B 857.9M 10.13B 9.62B
Dividends Per Share — — — — —
← Newer Page 2 of 2 Older →